"EC approves GSK’s RSV vaccine for adults aged 50-59 years" was originally created and published by Pharmaceutical Technology ...

It's been more than a year since the Food and Drug Administration approved the first vaccine to treat RSV. Since then, newly ...

Moderna Inc. (NASDAQ: MRNA) made headlines during the pandemic for its messenger ribonucleic acid (mRNA) technology used in ...

A UPMC pulmonologist talks about the symptoms, explains who is most at risk for a severe infection, and tells us how ...

Sanofi said on Monday the U.S. Food and Drug Administration has approved a manufacturing line for its and partner AstraZeneca ...

Annette Regan, University of San Francisco (THE CONVERSATION) The Food and Drug Administration approved and granted emergency use authorization on Aug. 22, 2024, for the newest, updated version of the ...

Nursing homes in New York are being urged to protect residents with the updated COVID-19 vaccine. The NYS Department of Health sent letters out to nursing facilities about ...

Focuses on ten product approvals through 2027Expects to submit next-generation COVID vaccine for approval in 2024Expects to submit flu/COVID ...

240452 in CMAJ (Canadian Medical Association Journal). RSV infections cause major illness, especially in infants and older adults, and rates of infection increase with age. There are now vaccines ...

With the stock now more than cut in half from its 52-week high, the company recently laid out a plan for its business at its ...

Delta Air Lines said in an update on Thursday that capacity across the industry was also “moderating” and that its revenue ...

Moderna plans to cut $1.1bn in costs by 2027, pausing and scrapping several R&D programs. See why I think further downside ...